Cell Source, Inc.

CLCS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $286.5K

Liabilities Breakdown FY2024

Total Liabilities: $18.8M